Med-IQ Logo
Get CME/CE
Uterine-Sparing Treatment Options for Symptomatic Uterine Fibroids
Webcast Webcast

Uterine-Sparing Treatment Options for Symptomatic Uterine Fibroids


This activity was developed by Med-IQ in collaboration with Duke University Health System Department of Clinical Education and Professional Development.


Med-IQ      Duke Medicine

Time to Complete:
15 minutes
Released:
6/30/17
Expires:
6/29/18
PDF:

Maximum Credits:

0.25 AMA PRA Category 1 Credit(s)
By clicking "Start," you are confirming that you have reviewed the CME information and read, understood, and unconditionally agreed to the Privacy Policy and Terms of Service.

Webcast Webcast
By clicking "Start," you are confirming that you have reviewed the CME information and read, understood, and unconditionally agreed to the Privacy Policy and Terms of Service.
Time to Complete:
15 minutes

Released:
6/30/17

Expires:
6/29/18

PDF:

Maximum Credits:
0.25 AMA PRA Category 1 Credit(s)
Share on:
Webcast Webcast
By clicking "Start," you are confirming that you have reviewed the CME information and read, understood, and unconditionally agreed to the Privacy Policy and Terms of Service.

Share on:


Time to Complete:
15 minutes
Released:
6/30/17
Expires:
6/29/18
PDF:


Maximum Credits:
0.25 AMA PRA Category 1 Credit(s)


Overview: In this complimentary, CME-certified Webcast, recorded live at the 2017 American College of Obstetricians and Gynecologists Annual Clinical and Scientific Meeting, an expert faculty member highlights uterine-sparing treatment options for women with symptomatic fibroids. These include medical-based therapies, uterine artery embolization, magnetic resonance–guided focused ultrasound surgery, radiofrequency volumetric thermal ablation, and myomectomy. The benefits and limitations of each approach as well as patient-specific considerations are examined.

Faculty

Angel Nieves, MD, PhD

Assistant Professor of Obstetrics and Gynecology

Duke University School of Medicine

Durham, NC


Disclosure Policy

Med-IQ requires any person in a position to control the content of an educational activity to disclose all relevant financial relationships with any commercial interest. The ACCME defines “relevant financial relationships” as those in any amount occurring within the past 12 months, including those of a spouse/life partner, that could create a conflict of interest (COI). Individuals who refuse to disclose will not be permitted to contribute to this CME activity in any way. Med-IQ has policies in place that will identify and resolve COIs prior to this educational activity. Med-IQ also requires faculty to disclose discussions of investigational products or unlabeled/unapproved uses of drugs or devices regulated by the US Food and Drug Administration.


Disclosure Statement

Angel Nieves, MD, PhD, has indicated no real or apparent conflicts.

The peer reviewers and activity planners have no financial relationships to disclose.


This activity has been approved for AMA PRA Category 1 Credit™.


Unless otherwise indicated, photographed subjects who appear within the content of this activity or on artwork associated with this activity are models; they are not actual patients or doctors.
Play Video
The trifecta of healthcare improvement: value-based care, quality improvement, and technology.

See how Med-IQ is helping to enhance patient outcomes in these short videos.

Scott Weber, CEO Med-IQ

From Volume to Value-Based Care: The Role of the CME Enterprise

Scott Weber, CEO,
Med-IQ

Allison Gardner, PhD, VP Educational Strategy and Content, Med-IQ

The Value of Quality Improvement and Education to Advance Healthcare

Allison Gardner, PhD,
VP Educational Strategy and Content,
Med-IQ

Dr. Glenn Treisman,
Department of Psychiatry, Johns Hopkins Medical Institute

The Pros and Cons of Technology on the Practice of Medicine

Dr. Glenn Treisman,
Department of Psychiatry,
Johns Hopkins Medical Institute


Need help? If you need to speak with a member of our team, please call (toll-free) 866 858 7434 or e-mail info@med-iq.com. For technical assistance, please refer to our support manual.